Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK

Table 9 Cross-sectional summary statistics for SF-36 scales, by age

SF-36 dimensions	Total (n = 44)			Age: < 40 years (n = 18)			Age: 40–60 years (n = 16)			Age: > 60 years (n = 10)			ANOVA P-value
SF-36 dimensions	Mean	SD	Median	Mean	SD	Median	Mean	SD	Median	Mean	SD	Median	ANOVA P-value
Physical dimensions
Physical functioning	44.89	29.99	45.00	52.22	30.55	50.00	45.00	29.50	37.50	31.50	27.89	32.50	0.219
Physical role limitations	34.66	42.19	12.50	41.67	45.37	25.00	31.25	40.31	12.50	27.50	41.58	0.00	0.652
Pain	53.41	32.17	50.00	58.33	33.21	62.50	45.31	33.19	50.00	57.50	28.99	50.00	0.460
General health	44.20	23.72	40.00	46.00	28.12	44.50	44.00	21.81	42.50	41.30	19.68	35.00	0.886
Mental dimensions
Emotional well-being	69.73	17.75	74.00	67.11	20.14	70.00	68.75	17.66	66.00	76.00	12.65	78.00	0.440
Emotional role limitations	65.91	40.34	83.33	72.22	36.60	100.00	54.17	41.94	66.67	73.33	43.89	100.00	0.352
Energy/fatigue	39.20	25.06	35.00	37.22	27.07	27.50	36.88	25.36	32.50	46.50	21.61	47.50	0.588
Social functioning	62.22	30.91	75.00	68.06	28.83	75.00	57.81	32.87	62.50	58.75	32.83	68.75	0.590

The sample is the first submitted instrument from each participant. The questionnaires were submitted between 07/2014 and 08/2019
SF-36, Short-form 36; PCS, Physical Component Score; MCS, Mental Component Score

ISSN: 1750-1172